Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;60(6):994-1000.
doi: 10.1002/pbc.24419. Epub 2012 Dec 19.

Children's Oncology Group's 2013 blueprint for research: renal tumors

Jeffrey S Dome  1 , Conrad V Fernandez, Elizabeth A Mullen, John A Kalapurakal, James I Geller, Vicki Huff, Eric J Gratias, David B Dix, Peter F Ehrlich, Geetika Khanna, Marcio H Malogolowkin, James R Anderson, Arlene Naranjo, Elizabeth J Perlman; COG Renal Tumors Committee
Affiliations
Review

Children's Oncology Group's 2013 blueprint for research: renal tumors

Jeffrey S Dome et al. Pediatr Blood Cancer. 2013 Jun.

Abstract

Renal malignancies are among the most prevalent pediatric cancers. The most common is favorable histology Wilms tumor (FHWT), which has 5-year overall survival exceeding 90%. Other pediatric renal malignancies, including anaplastic Wilms tumor, clear cell sarcoma, malignant rhabdoid tumor, and renal cell carcinoma, have less favorable outcomes. Recent clinical trials have identified gain of chromosome 1q as a prognostic marker for FHWT. Upcoming studies will evaluate therapy adjustments based on this and other novel biomarkers. For high-risk renal tumors, new treatment regimens will incorporate biological therapies. A research blueprint, viewed from the perspective of the Children's Oncology Group, is presented.

PubMed Disclaimer

References

    1. Dome JS, Liu T, Krasin M, et al. Improved survival for patients with recurrent Wilms tumor: The experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol. 2002;24:192–198. - PubMed
    1. Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008;50(2):236–241. - PubMed
    1. Ha TC, Spreafico F, Graf N, et al. An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour. Eur J Cancer. 2012 Sep 4; - PubMed
    1. Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006;24(15):2352–2358. - PubMed
    1. Graf N, van Tinteren H, Bergeron C, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012 Jul 11; - PubMed

Publication types